Latest Articles
BBC star details 'intense and painful' health condition after collapsing during park run - Wales Online
BBC star details 'intense and painful' health condition after collapsing during park run Wales Online
Published: May 14, 2026, 12:32 p.m.
BBC star left 'on floor in intense pain' as she shares reality of debilitating condition - Glasgow Live
BBC star left 'on floor in intense pain' as she shares reality of debilitating condition Glasgow Live
Published: May 14, 2026, 12:32 p.m.
Karyopharm Therapeutics stock (US48576U1060): Q1 revenue beats estimates, trial enrollment complete - AD HOC NEWS
Karyopharm Therapeutics stock (US48576U1060): Q1 revenue beats estimates, trial enrollment complete AD HOC NEWS
Published: May 14, 2026, 12:26 p.m.
"My 30 year wait for an endometriosis diagnosis left me walking with a cane!" - ITVX
"My 30 year wait for an endometriosis diagnosis left me walking with a cane!" ITVX
Published: May 14, 2026, 11:52 a.m.
Karyopharm completes endometrial cancer trial enrollment - Investing.com
Karyopharm completes endometrial cancer trial enrollment Investing.com
Published: May 14, 2026, 11:52 a.m.
Karyopharm completes endometrial cancer trial enrollment By Investing.com - Investing.com Canada
Karyopharm completes endometrial cancer trial enrollment By Investing.com Investing.com Canada
Published: May 14, 2026, 11:45 a.m.
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M - TradingView
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M TradingView
Published: May 14, 2026, 11:33 a.m.
Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M - Stock Titan
Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M Stock Titan
Published: May 14, 2026, 11:30 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire
Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo
Published: May 14, 2026, 11:30 a.m.
Link copied to clipboard!